`
Wednesday, 16 August 2017

Vaccines News

  • ABIVAX to market typhoid, meningococcus vaccines in Asia

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2014

    Singapore: ABIVAX, Europe-based clinical stage biopharmaceutical company developing and commercializing anti-viral compounds and human vaccines, has collaborated with Finlay Institute, Hava...Read more

  • Global respiratory syncytial virus treatment market to touch $2.3 bn by 2024

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 14 Jan, 2016

    Singapore: The global Respiratory Syncytial Virus (RSV) treatment market will expand to unprecedented levels over the next decade, rising from approximately $640 million in 2014 to over $2....Read more

  • Bill & Melinda Gates Foundation supports Takeda with $38 m to eradicate polio

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 10 May, 2016

    Japan's Takeda Pharmaceutical Company Limited has announced a partnership with the Bill & Melinda Gates Foundation to support global polio eradication in developing countries. With th...Read more

  • Merck gets FDA nod for Bridion

    Vaccines |  Regulatory | By BioSpectrum Bureau | 0 Comment | 22 Dec, 2015

    Singapore: Merck (MSD) has recieved US Food and Drug Administration (FDA) approval for Bridion (sugammadex) Injection 100 mg/mL (equivalent to 108.8 mg/mL sugammadex sodium) for the reversa...Read more

  • BioDiem gets hepatitis vaccine tech from Canberra univ

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2012

    Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to license a novel vaccine technology from the University of Canberra, expan...Read more

  • Infect mosquitoes with Wolbachia, stop diseases

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2013

    Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected with the bacteria Wolbachia lose their ability to spread diseases such ...Read more

  • Takeda close to releasing Norovirus vaccine

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013

    Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies on a vaccine against norovirus, by the end of this year. Takeda's vacc...Read more

  • China to set up a new vaccine tracking system

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 27 Apr, 2016

    Singapore: According to a recent decision publicized by the Chinese government, wholesalers will no longer be allowed to trade vaccines in the country. The decision comes as a huge scandal ...Read more

  • Yisheng BioPharma gets positive result in rabies vaccine trial

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 04 Jan, 2016

    Singapore: Yisheng Biopharma, China based biopharmaceutical company, has recieved positive topline results from Phase I clinical trial of PIKA rabies vaccine, an investigational vaccine des...Read more

  • China's Hualan Bio gets WHO nod for influenza vaccine

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2015

    Singapore: China based Hualan Bio has recieved world health organization (WHO) pre-qualification approval for influenza vaccine and is taken into UN purchase plan. Flu is one of the most s...Read more

  • Teikoku Pharma gets USFDA nod for non-alcohol docetaxel injection

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 04 Jan, 2016

    Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the treatment of breast cancer, non-small cell lung cancer, prostate cancer,...Read more

  • German firm proceeds on ebola vaccine trial

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2015

    Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the clinical trial of its investigational vaccine against Ebola virus diseas...Read more

  • Merck's Ebola vaccine found promising in clinical trials

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2015

    Singapore: In a recent interim study published in the Lancet medical journal, Merck's Ebola vaccine was found to be "highly effective," in clinical trials. The vaccine was tested on more th...Read more

  • Teva recalls Adrucil injection for potential foriegn particle presence

    Vaccines |  Regulatory | By BioSpectrum Bureau | 0 Comment | 28 Jul, 2015

    Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential presence of particulate matter identified as aggregate of silicone rubber...Read more

  • Drug resistance keeps malaria threat alive in India

    Vaccines |  Analysis | By Rahul Koul Koul | 0 Comment | 02 Jul, 2012

    The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 percent, says a report by ORG IMS in Nov 2011. According to statistics...Read more

  • New vaccine against Hepatatis B developed by Cuba

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 17 Aug, 2015

    Singapore: Researchers from Cuba have developed a new vaccine for treatment of chronic hepatitis B. The vaccine HeberNasvac, developed in cooperation French company Abivax, is currently und...Read more

  • Malaria vaccine, Mosquirix, gets European nod

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2015

    Singapore: GlaxoSmithKline has received a positive opinion for its Malaria vaccine candidate from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...Read more

  • Novavax's Ebola vaccine shows promise in human trial

    Vaccines |  News | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2015

    Singapore: US-based Novavax recently announced that its experimental candidate vaccine for Ebola showed promise in early stage human clinical trial. The vaccine induced a substantial immune...Read more

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls